Business Wire

bioAffinity Technologies’ CyPath® Lung to Be Featured at Cleveland Clinic Annual ...

SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on noninvasive diagnostics and early cancer detection, announces that its CyPath® ...
Medscape

Non-Risk-Based Lung Cancer Screening Tied to Better Survival

COPENHAGEN, Denmark — Screening individuals for lung cancer with low-dose CT without preselection based on their risk profile is associated with a substantial reduction in lung cancer-specific ...
Medical Xpress

A new AI model could help doctors detect lung cancer earlier

Lung cancer remains the leading cause of cancer-related deaths worldwide, accounting for nearly one in five cancer deaths—around 1.8 million lives lost each year. One of the main reasons is late ...
News Medical

Dual perspective AI model achieves high accuracy in early lung cancer diagnosis

Lung cancer remains the leading cause of cancer-related deaths worldwide, accounting for nearly one in five cancer deaths - around 1.8 million lives lost each year. One of the main reasons is late ...